BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24047492)

  • 1. Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.
    Fernlund E; Lundin C; Hertervig E; Kongstad O; Alders M; Platonov P
    Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):471-8. PubMed ID: 24047492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
    Delannoy E; Sacher F; Maury P; Mabo P; Mansourati J; Magnin I; Camous JP; Tournant G; Rendu E; Kyndt F; Haïssaguerre M; Bézieau S; Guyomarch B; Le Marec H; Fressart V; Denjoy I; Probst V
    Europace; 2013 Dec; 15(12):1805-11. PubMed ID: 23867365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome.
    Haruna Y; Kobori A; Makiyama T; Yoshida H; Akao M; Doi T; Tsuji K; Ono S; Nishio Y; Shimizu W; Inoue T; Murakami T; Tsuboi N; Yamanouchi H; Ushinohama H; Nakamura Y; Yoshinaga M; Horigome H; Aizawa Y; Kita T; Horie M
    Hum Mutat; 2007 Feb; 28(2):208. PubMed ID: 17221872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry.
    Barajas-Martinez H; Hu D; Ontiveros G; Caceres G; Desai M; Burashnikov E; Scaglione J; Antzelevitch C
    Circ Cardiovasc Genet; 2011 Feb; 4(1):51-7. PubMed ID: 21148745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations.
    Miyamoto K; Aiba T; Kimura H; Hayashi H; Ohno S; Yasuoka C; Tanioka Y; Tsuchiya T; Yoshida Y; Hayashi H; Tsuboi I; Nakajima I; Ishibashi K; Okamura H; Noda T; Ishihara M; Anzai T; Yasuda S; Miyamoto Y; Kamakura S; Kusano K; Ogawa H; Horie M; Shimizu W
    Heart Rhythm; 2015 Mar; 12(3):596-603. PubMed ID: 25496985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Andersen-Tawil syndrome: Clinical presentation and predictors of symptomatic arrhythmias - Possible role of polymorphisms K897T in KCNH2 and H558R in SCN5A gene.
    Krych M; Biernacka EK; Ponińska J; Kukla P; Filipecki A; Gajda R; Hasdemir C; Antzelevitch C; Kosiec A; Szperl M; Płoski R; Trusz-Gluza M; Mizia-Stec K; Hoffman P
    J Cardiol; 2017 Nov; 70(5):504-510. PubMed ID: 28336205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rarity and phenotypic heterogeneity provide challenges in the diagnosis of Andersen-Tawil syndrome: Two cases presenting with ECGs mimicking catecholaminergic polymorphic ventricular tachycardia (CPVT).
    Tully I; Atherton J; Hunt L; Ingles J; Semsarian C; McGaughran J
    Int J Cardiol; 2015 Dec; 201():473-5. PubMed ID: 26322597
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrocardiogram in Andersen-Tawil syndrome. New electrocardiographic criteria for diagnosis of type-1 Andersen-Tawil syndrome.
    Kukla P; Biernacka EK; Baranchuk A; Jastrzebski M; Jagodzinska M
    Curr Cardiol Rev; 2014 Aug; 10(3):222-8. PubMed ID: 24827800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden cardiac death in Andersen-Tawil syndrome.
    Peters S; Schulze-Bahr E; Etheridge SP; Tristani-Firouzi M
    Europace; 2007 Mar; 9(3):162-6. PubMed ID: 17272325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different responses to exercise between Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia.
    Inoue YY; Aiba T; Kawata H; Sakaguchi T; Mitsuma W; Morita H; Noda T; Takaki H; Toyohara K; Kanaya Y; Itoi T; Mitsuhashi T; Sumitomo N; Cho Y; Yasuda S; Kamakura S; Kusano K; Miyamoto Y; Horie M; Shimizu W
    Europace; 2018 Oct; 20(10):1675-1682. PubMed ID: 29309601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype variability in patients carrying KCNJ2 mutations.
    Kimura H; Zhou J; Kawamura M; Itoh H; Mizusawa Y; Ding WG; Wu J; Ohno S; Makiyama T; Miyamoto A; Naiki N; Wang Q; Xie Y; Suzuki T; Tateno S; Nakamura Y; Zang WJ; Ito M; Matsuura H; Horie M
    Circ Cardiovasc Genet; 2012 Jun; 5(3):344-53. PubMed ID: 22589293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular genetic diagnostics of the cause of ventricular arrhythmias in children].
    Brøndberg AK; Bjerre JV; Nielsen JC; Jensen HK
    Ugeskr Laeger; 2015 Sep; 177(38):V04150366. PubMed ID: 26376421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mosaic KCNJ2 mutation in Andersen-Tawil syndrome: targeted deep sequencing is useful for the detection of mosaicism.
    Hasegawa K; Ohno S; Kimura H; Itoh H; Makiyama T; Yoshida Y; Horie M
    Clin Genet; 2015 Mar; 87(3):279-83. PubMed ID: 24635491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Andersen-Tawil syndrome: clinical and molecular aspects.
    Nguyen HL; Pieper GH; Wilders R
    Int J Cardiol; 2013 Dec; 170(1):1-16. PubMed ID: 24383070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1.
    Mazzanti A; Guz D; Trancuccio A; Pagan E; Kukavica D; Chargeishvili T; Olivetti N; Biernacka EK; Sacilotto L; Sarquella-Brugada G; Campuzano O; Nof E; Anastasakis A; Sansone VA; Jimenez-Jaimez J; Cruz F; Sánchez-Quiñones J; Hernandez-Afonso J; Fuentes ME; Średniawa B; Garoufi A; Andršová I; Izquierdo M; Marinov R; Danon A; Expósito-García V; Garcia-Fernandez A; Muñoz-Esparza C; Ortíz M; Zienciuk-Krajka A; Tavazzani E; Monteforte N; Bloise R; Marino M; Memmi M; Napolitano C; Zorio E; Monserrat L; Bagnardi V; Priori SG
    J Am Coll Cardiol; 2020 Apr; 75(15):1772-1784. PubMed ID: 32299589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Andersen-Tawil syndrome: report of 3 novel mutations and high risk of symptomatic cardiac involvement.
    Kostera-Pruszczyk A; Potulska-Chromik A; Pruszczyk P; Bieganowska K; Miszczak-Knecht M; Bienias P; Szczałuba K; Lee HY; Quinn E; Ploski R; Kaminska A; Ptáček LJ
    Muscle Nerve; 2015 Feb; 51(2):192-6. PubMed ID: 24861851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Andersen-Tawil syndrome: deep phenotyping reveals significant cardiac and neuromuscular morbidity.
    Vivekanandam V; Männikkö R; Skorupinska I; Germain L; Gray B; Wedderburn S; Kozyra D; Sud R; James N; Holmes S; Savvatis K; Fialho D; Merve A; Pattni J; Farrugia M; Behr ER; Marini-Bettolo C; Hanna MG; Matthews E
    Brain; 2022 Jun; 145(6):2108-2120. PubMed ID: 34919635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of any cardiac involvement in a patient with Andersen-Tawil syndrome associated with the c.574A→G mutation in KCNJ2.
    Modoni A; Bianchi ML; Vitulano N; Pagliarani S; Perna F; Sanna T; Rizzo V; Silvestri G
    Cardiology; 2011; 120(4):200-3. PubMed ID: 22286118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and neurophysiological variability in Andersen-Tawil syndrome.
    Kokubun N; Aoki R; Nagashima T; Komagamine T; Kuroda Y; Horie M; Hirata K
    Muscle Nerve; 2019 Dec; 60(6):752-757. PubMed ID: 31509255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype.
    Zhang L; Benson DW; Tristani-Firouzi M; Ptacek LJ; Tawil R; Schwartz PJ; George AL; Horie M; Andelfinger G; Snow GL; Fu YH; Ackerman MJ; Vincent GM
    Circulation; 2005 May; 111(21):2720-6. PubMed ID: 15911703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.